Top 10 Stock Picks of Srini Akkaraju and Michael Dybbs' Samsara BioCapital
In this article, we discuss the top 10 stock picks of Srini Akkaraju and Michael Dybbs' Samsara BioCapital.
Hedge Fund - Samsara BioCapital
Get Email AlertsSrini Akkaraju And Michael Dybbs Bio, Returns, AUM, Net Worth
Manager biography is currently missing.
Fund Profile
Filing Period:
| Fund Name: | Samsara BioCapital |
| Manager | Srini Akkaraju And Michael Dybbs |
| Portfolio Value | $464,646,728,000 |
| Change This QTR | +1083.44% |
Top 13F Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Security | Ticker | Shares | Value (x$1000) | Activity | % Port | History |
|---|---|---|---|---|---|---|---|
| 1. | Chinook Therapeutics Inc | 5,161,888 | $135,241,466 | 29.1% | |||
| 2. | SRRK | 4,598,828 | $41,619,393 | 8.95% | |||
| 3. | ACLX | 957,451 | $29,661,832 | -11% | 6.38% | ||
| 4. | GRPH | 8,459,314 | $28,084,922 | 6.04% | |||
| 5. | VRNA | 695,001 | $18,160,376 | -26% | 3.9% |
News, Interviews and Investor Letters
15 Biotech Stocks to Buy Now According to Srini Akkaraju and Michael Dybbs' Samsara BioCapital
In this article, we will discuss 15 biotech stocks to buy now according to Srini Akkaraju and Michael Dybbs' Samsara BioCapital.
